Sveriges Riksbank
| Bid procedure, 2021-02-26 | |
| Bonds | SWEDISH GOVERNMENT: 1053. SE0002829192. 2039-03-30 SWEDISH GOVERNMENT: 1063, SE0015193313, 2045-11-24 |
| Bid date | 2021-02-26 |
| Bid times | 09.00-10.00 (CET/CEST) on the Bid date |
| Requested volume (corresponding nominal amount) | 1053: 1000 mln SEK +/-500 mln SEK 1063: 500 mln SEK +/-250 mln SEK |
| Highest permitted bid volume (corresponding nominal amount) | 1053: 1000 mln SEK per bid 1063: 500 mln SEK per bid |
| Lowest permitted bid volume (corresponding nominal amount) | SEK 50 million per bid |
| Expected allocation time | Not later than 10.15 (CET/CEST) on the Bid date |
| Delivery and payment date | 2021-03-02 |
| Delivery of bonds | To the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 |
Stockholm, 2021-02-19
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Global Allergy and Airways Patient Platform26.10.2025 20:17:14 CET | Press release
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
ARETI International Group26.10.2025 18:41:15 CET | Press release
ARETI International Group, Headed by Igor Makarov, Partners with INEX CLUB to Support the Mayflower Gran Prix Cyprus 2025
Novartis Pharma AG26.10.2025 18:00:00 CET | Press release
Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
mediCAD Hectec GmbH26.10.2025 12:45:00 CET | Press release
mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI Integration
Novartis Pharma AG25.10.2025 17:00:00 CEST | Press release
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
